SHIRPA, a protocol for behavioral assessment: validation for longitudinal study of neurological dysfunction in mice

Neurosci Lett. 2001 Jun 22;306(1-2):89-92. doi: 10.1016/s0304-3940(01)01885-7.

Abstract

Mouse models of neurological abnormalities are only valuable if accurately assessed. The three-stage SHIRPA procedure is used for the standardised assessment of mouse phenotype and has been reported in a high throughput experiment in which different mutants were ascertained at one age point using stage 1 of the protocol. In this study we have validated SHIRPA using a large cohort with one single mutation, 'legs at odd angles that causes neurological dysfunction. The cohort aged from 1 to 16 months during this study and this is the first longitudinal SHIRPA analysis.

MeSH terms

  • Animals
  • Behavior, Animal / physiology*
  • Body Weight / physiology
  • Central Nervous System Diseases / congenital*
  • Central Nervous System Diseases / diagnosis*
  • Central Nervous System Diseases / physiopathology
  • Disease Models, Animal
  • Female
  • Gait Disorders, Neurologic / congenital
  • Gait Disorders, Neurologic / diagnosis
  • Gait Disorders, Neurologic / pathology
  • Genotype
  • Longitudinal Studies
  • Male
  • Mice
  • Mice, Neurologic Mutants / abnormalities*
  • Mice, Neurologic Mutants / physiology
  • Movement / physiology
  • Phenotype
  • Physical Examination / methods*
  • Posture / physiology
  • Psychomotor Performance / physiology
  • Reproducibility of Results
  • Sex Characteristics